Arash Hassantoufighi is a Rheumatology/Immunology physician. OpenAlex indexes 10 publications with 316 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
176 Health Care Ln
Martinsburg, WV 254014010
Telephone
301-996-7311Provider last certified this registry record 6 Dec 2020.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202525 payments
- Novartis Pharmaceuticals CorporationProgram year202519 payments
- UCB, Inc.Program year202523 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
95.4%Other drugs affecting bone structure and mineralization64.8%Romosozumab-aqqg100%Part B, office-administered≥12 patientsRANK Ligand Inhibitor30.2%Denosumab100%Part B, office-administered≥62 patients+ 2 more classes in this area
Dermatology
1.6%Corticosteroid1.6%Triamcinolone acetonide100%Part B, office-administered≥42 patientsMetabolism & gastrointestinal
1.3%Corticosteroid1.2%Prednisone100%Part D≥84 patientsAntidiarrheal microorganisms0.1%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AB0601 UTILIZATION OF A MULTISPECIALTY TEAM FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS REDUCES PATIENT MORBIDITY
Annals of the Rheumatic Diseases
2019 - Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Clinical Infectious Diseases
2010
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”